From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Medical Screening Technologies for NASA

by Global Biodefense Staff
March 19, 2014
National Aeronautics and Space Administration

The National Aeronautics and Space Administration (NASA) is seeking parties interested in collaborative development of technologies associated with health screening and health status monitoring.

Screening technologies sought are to personalize in-flight medical planning and care, pharmacogenomics, radiation exposure-associated risks, and the development of capabilities for prevention, screening for risk factors, and radiation biomarkers for early diagnosis and effective treatment.

Health indicators to be addressed include: malignancies, cataracts, increased intracranial pressure (ICP), cardiovascular risks, bone loss, oxidative stress, renal stone formation, sleep disorders, anxiety/depression, susceptibility to radiation and elevated CO2 levels. Particular importance is given to radiation exposure-associated risks.

Screening technologies to personalize in-flight medical planning and care include: Pharmacogenomics; Disease and therapeutic monitoring markers for better diagnosis and treatment; and Genomic screening and health status markers (predictive and preventive value).

Examples of applicable NASA Technologies include: Isotopic biomarkers for rapid assessment of bone mineral balance in biomedical applications;Accurate and Rapid Test for diagnosis of Viral Infections of the Eye; and On Orbit Immuno-based, Label-free, White Blood Cell Counting System with MicroElectroMechanical Sensor (MEMS) Technology (OILWBCS-MEMS).

According to NASA, co-development project under this effort may produce new Intellectual Property that could be jointly owned by NASA and the partner or may become the property of the partner.

Further details are available under Solicitation Number: NNJ14ZBH007L.

From Our Partners
Tags: BiomarkersRadiation

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC